
    
      Subjects will be treated with platelet rich fibrin matrix into the skin of the inner aspect
      of the upper arm. Injected areas will be monitored clinically and will also undergo biopsies
      between 30 minutes and 12 weeks after treatment. Specimen of treated areas will undergo
      histologic and biochemical analysis and comparison to standard laboratory control specimen of
      untreated skin.
    
  